Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuoqing SAN for Ulcerative Colitis
NCT06667934Phase 2Not yet recruiting
- Start
- Oct 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Zuoqing San in ulcerative colitis (UC). Planned start Oct 2024; status: not yet recruiting.
02
Drugs
Zuoqing San
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06667934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06667934.